{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:01:19Z","timestamp":1781766079261,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00810-w","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T05:33:33Z","timestamp":1765344813000},"page":"341-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex differences in the antidepressant-like response induced by the imidazoline-2 receptor compound 12d, a (3-phenylcarbamoyl-3,4-dihydro\u20112H\u2011pyrrol-2-yl)phosphonate"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3714-0181","authenticated-orcid":false,"given":"Elena","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-1214","authenticated-orcid":false,"given":"Sandra","family":"Ledesma-Corvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3326-6281","authenticated-orcid":false,"given":"Fernando","family":"Y\u00e1\u00f1ez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Mateu-Mercader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0371-1329","authenticated-orcid":false,"given":"Andrea","family":"Bag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9117-8239","authenticated-orcid":false,"given":"Carmen","family":"Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-3775","authenticated-orcid":false,"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"810_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1001\/archpsyc.1996.01830090049008","volume":"53","author":"JA Garc\u00eda-Sevilla","year":"1996","unstructured":"Garc\u00eda-Sevilla JA, Escrib\u00e1 PV, Sastre M, Walzer C, Busquets X, Jaquet G, et al. Immunodetection and quantitation of Imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiatr. 1996;53:803\u201310.","journal-title":"Arch Gen Psychiatr"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00001756-199612200-00034","volume":"8","author":"JA Garc\u00eda-Sevilla","year":"1996","unstructured":"Garc\u00eda-Sevilla JA, Escrib\u00e1 PV, Busquets X, Walzer C, Guim\u00f3n J. Platelet imidazoline receptors and regulatory G proteins in patients with major depression. NeuroReport. 1996;8:169\u201372.","journal-title":"NeuroReport"},{"key":"810_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0197-0186(96)00032-0","volume":"30","author":"M Sastre","year":"1997","unstructured":"Sastre M, Garc\u00eda-Sevilla JA. Densities of I2-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. Neurochem Int. 1997;30:63\u201372.","journal-title":"Neurochem Int"},{"key":"810_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1749-6632.1999.tb09388.x","volume":"881","author":"JA Garc\u00eda-Sevilla","year":"1999","unstructured":"Garc\u00eda-Sevilla JA, Escrib\u00e1 PV, Guim\u00f3n J. Imidazoline receptors and human brain disorders. Ann NY Acad Sci. 1999;881:392\u2013409.","journal-title":"Ann NY Acad Sci"},{"key":"810_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1196\/annals.1304.014","volume":"1009","author":"F Aricioglu","year":"2003","unstructured":"Aricioglu F, Altunbas H. Is Agmatine an endogenous anxiolytic\/antidepressant agent? Ann N Y Acad Sci. 2003;1009:136\u201340.","journal-title":"Ann N Y Acad Sci"},{"key":"810_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1995.tb32397.x","volume":"763","author":"D Nutt","year":"1995","unstructured":"Nutt D, French N, Handley S, Hudson A, Husbands S, Jackson H, et al. Functional studies of specific Imidazoline-2 receptor ligands. Ann NY Acad Sci. 1995;763:125\u201339.","journal-title":"Ann NY Acad Sci"},{"key":"810_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00213-003-1392-3","volume":"167","author":"DP Finn","year":"2003","unstructured":"Finn DP, Mart\u00ed O, Harbuz MS, Vall\u00e8s A, Belda X, M\u00e1rquez C, et al. Behavioral, neuroendocrine and neurochemical effects of the Imidazoline I2 receptor selective ligand BU224 in Naive rats and rats exposed to the stress of the forced swim test. Psychopharmacology. 2003;167:195\u2013202.","journal-title":"Psychopharmacology"},{"key":"810_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pnpbp.2011.11.005","volume":"37","author":"R Tonello","year":"2012","unstructured":"Tonello R, Villarinho JG, Sant\u2019Anna GS, Tamiozzo L, Machado P, Trevisan G, et al. The potential antidepressant-like effect of Imidazoline I2 ligand 2-BFI in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37:15\u201321.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"810_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/FBP.0000000000000454","volume":"30","author":"JN Siemian","year":"2019","unstructured":"Siemian JN, Shang L, Seaman RW Jr, Zhu Q, Zhang Y, Li JX. Effects of Imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats. Behav Pharmacol. 2019;30:429\u201334.","journal-title":"Behav Pharmacol"},{"key":"810_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00210-020-02042-6","volume":"394","author":"E Hern\u00e1ndez-Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez E, Garc\u00eda-Fuster MJ. Evaluating the effects of 2-BFI and tracizoline, two potent I2-imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:989\u201396.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"810_CR11","doi-asserted-by":"publisher","first-page":"173527","DOI":"10.1016\/j.pbb.2023.173527","volume":"223","author":"E Hern\u00e1ndez-Hern\u00e1ndez","year":"2023","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez E, Ledesma-Corvi S, Y\u00e1\u00f1ez-G\u00f3mez F, Garau C, G\u00e1lvez-Melero L, Bag\u00e1n A, et al. Sex differences in the antidepressant-like response and molecular events induced by the imidazoline-2 receptor agonist CR4056 in rats. Pharmacol Biochem Behav. 2023;223:173527.","journal-title":"Pharmacol Biochem Behav"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/pharmaceutics12050475","volume":"12","author":"F Vasilopoulou","year":"2020","unstructured":"Vasilopoulou F, Bagan A, Rodriguez-Arevalo S, Escolano C, Gri\u00f1\u00e1n-Ferr\u00e9 C, Pall\u00e0s M. Amelioration of BPSD-like phenotype and cognitive decline in SAMP8 mice model accompanied by molecular changes after treatment with I2-imidazoline receptor ligand MCR5. Pharmaceutics. 2020;12:475.","journal-title":"Pharmaceutics"},{"key":"810_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/026988110101500104","volume":"15","author":"MF O\u2019Neill","year":"2001","unstructured":"O\u2019Neill MF, Osborne DJ, Woodhouse SM, Conway MW. Selective Imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice. J Psychopharmacol. 2001;15:18\u201322.","journal-title":"J Psychopharmacol"},{"key":"810_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s43440-020-00148-5","volume":"73","author":"E Hern\u00e1ndez-Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez E, Garc\u00eda-Sevilla JA, Garc\u00eda-Fuster MJ. Exploring the antidepressant-like potential of the selective I2-imidazoline receptor ligand LSL60101 in adult male rats. Pharmacol Rep. 2021;73:288\u201395.","journal-title":"Pharmacol Rep"},{"key":"810_CR15","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1021\/acs.jmedchem.4c01644","volume":"68","author":"A Bag\u00e1n","year":"2025","unstructured":"Bag\u00e1n A, L\u00f3pez-Ruiz A, Ab\u00e1s S, Ruiz-Cantero MC, Vasilopoulou F, Taboada-Jara T, et al. Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 receptor ligands with Anti-Alzheimer and analgesic properties. J Med Chem. 2025;68:2551\u201373.","journal-title":"J Med Chem"},{"key":"810_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","volume":"44","author":"TA LeGates","year":"2019","unstructured":"LeGates TA, Kvarta MD, Thompson SM. Sex differences in antidepressant efficacy. Neuropsychopharmacology. 2019;44:140\u201354.","journal-title":"Neuropsychopharmacology"},{"key":"810_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.euroneuro.2020.10.008","volume":"41","author":"R Garc\u00eda-Cabrerizo","year":"2020","unstructured":"Garc\u00eda-Cabrerizo R, Ledesma-Corvi S, Bis-Humbert C, Garc\u00eda-Fuster MJ. Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: regulation of the early stages of hippocampal neurogenesis. Eur Neuropsychopharmacol. 2020;41:132\u201345.","journal-title":"Eur Neuropsychopharmacol"},{"key":"810_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41398-022-01994-y","volume":"12","author":"S Ledesma-Corvi","year":"2022","unstructured":"Ledesma-Corvi S, Hern\u00e1ndez-Hern\u00e1ndez E, Garc\u00eda-Fuster MJ. Exploring Pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective. Transl Psychiatry. 2022;12:220.","journal-title":"Transl Psychiatry"},{"key":"810_CR19","doi-asserted-by":"publisher","first-page":"117781","DOI":"10.1016\/j.biopha.2024.117781","volume":"182","author":"J Jornet-Plaza","year":"2025","unstructured":"Jornet-Plaza J, Ledesma-Corvi S, Garc\u00eda-Fuster MJ. Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile. Biomed Pharmacother. 2025;182:117781.","journal-title":"Biomed Pharmacother"},{"key":"810_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s43440-025-00750-5","volume":"77","author":"L G\u00e1lvez-Melero","year":"2025","unstructured":"G\u00e1lvez-Melero L, Beruete-Fresnillo I, Ledesma-Corvi S, Garc\u00eda-Fuster MJ. Adolescent Cannabidiol treatment produces antidepressant-like effects without compromising long-term cognition in rats. Pharmacol Rep. 2025;77:999\u20131010.","journal-title":"Pharmacol Rep"},{"key":"810_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainresbull.2022.07.009","volume":"188","author":"AD Flores","year":"2022","unstructured":"Flores AD, Yu WS, Fung ML, Lim LW. Neuromodulation and hippocampal neurogenesis in depression: A scoping review. Brain Res Bull. 2022;188:92\u2013107.","journal-title":"Brain Res Bull"},{"issue":"2","key":"810_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0269881112450785","volume":"27","author":"C Garau","year":"2013","unstructured":"Garau C, Miralles A, Garc\u00eda-Sevilla JA. Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain. J Psychopharmacol. 2013;27(2):123\u201334.","journal-title":"J Psychopharmacol"},{"key":"810_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13311-018-00681-5","volume":"16","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2019","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Vasilopoulou F, Ab\u00e1s S, Rodr\u00edguez-Ar\u00e9valo S, Bag\u00e1n A, Sureda FX, et al. Behavioral and cognitive improvement induced by novel Imidazoline I2 receptor ligands in female SAMP8 mice. Neurotherapeutics. 2019;16:416\u201331.","journal-title":"Neurotherapeutics"},{"key":"810_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1021\/acschemneuro.6b00426","volume":"8","author":"S Ab\u00e1s","year":"2017","unstructured":"Ab\u00e1s S, Erdozain AM, Keller B, Rodr\u00edguez-Ar\u00e9valo S, Callado LF, Garc\u00eda-Sevilla JA, et al. Neuroprotective effects of a structurally new family of high affinity Imidazoline I2 receptor ligands. ACS Chem Neurosci. 2017;8:737\u201342.","journal-title":"ACS Chem Neurosci"},{"key":"810_CR25","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1021\/acs.jmedchem.9b02080","volume":"63","author":"S Ab\u00e1s","year":"2020","unstructured":"Ab\u00e1s S, Rodr\u00edguez-Ar\u00e9valo S, Bag\u00e1n A, Gri\u00f1\u00e1n-Ferr\u00e9 C, Vasilopoulou F, Brocos-Mosquera I, et al. Bicyclic \u03b1-iminophosphonates as high affinity Imidazoline I2 receptor ligands for alzheimer\u2019s disease. J Med Chem. 2020;63:3610\u201333.","journal-title":"J Med Chem"},{"key":"810_CR26","doi-asserted-by":"publisher","first-page":"113540","DOI":"10.1016\/j.ejmech.2021.113540","volume":"222","author":"S Rodr\u00edguez-Ar\u00e9valo","year":"2021","unstructured":"Rodr\u00edguez-Ar\u00e9valo S, Bag\u00e1n A, Gri\u00f1\u00e1n-Ferr\u00e9 C, Vasilopoulou F, Pall\u00e0s M, Brocos-Mosquera I, et al. Benzofuranyl-2-imidazoles as Imidazoline I2 receptor ligands for alzheimer\u2019s disease. Eur J Med Chem. 2021;222:113540.","journal-title":"Eur J Med Chem"},{"key":"810_CR27","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00213-016-4342-6","volume":"233","author":"MJ Garc\u00eda-Fuster","year":"2016","unstructured":"Garc\u00eda-Fuster MJ, Garc\u00eda-Sevilla JA. Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD\/FADD ratio after chronic Desipramine and Fluoxetine administration. Psychopharmacology. 2016;233:2955\u201371.","journal-title":"Psychopharmacology"},{"key":"810_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.npp.1301040","volume":"32","author":"MJ Garc\u00eda-Fuster","year":"2007","unstructured":"Garc\u00eda-Fuster MJ, Miralles A, Garc\u00eda-Sevilla JA. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1\/2 MAP kinase pathway. Neuropsychopharmacology. 2007;32:399\u2013411.","journal-title":"Neuropsychopharmacology"},{"key":"810_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neubiorev.2018.04.001","volume":"90","author":"CRAF Diniz","year":"2018","unstructured":"Diniz CRAF, Casarotto PC, Resstel L, Joca SRL. Beyond good and evil: A putative continuum-sorting hypothesis for the functional role of proBDNF\/BDNF-propeptide\/mBDNF in antidepressant treatment. Neurosci Biobehav Rev. 2018;90:70\u201383.","journal-title":"Neurosci Biobehav Rev"},{"key":"810_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell. 2021;184:1299\u2013313.","journal-title":"Cell"},{"key":"810_CR31","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18:e3000411.","journal-title":"PLoS Biol"},{"key":"810_CR32","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41386-019-0524-3","volume":"44","author":"AM Beltz","year":"2019","unstructured":"Beltz AM, Beery AK, Becker JB. Analysis of sex differences in pre-clinical and clinical data sets. Neuropsychopharmacology. 2019;44:2155\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"810_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13293-016-0087-5","volume":"7","author":"JB Becker","year":"2016","unstructured":"Becker JB, Prendergast BJ, Liang JW. Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol Sex Differ. 2016;7:34.","journal-title":"Biol Sex Differ"},{"key":"810_CR34","doi-asserted-by":"publisher","first-page":"104962","DOI":"10.1016\/j.neubiorev.2022.104962","volume":"143","author":"AM Kaluve","year":"2022","unstructured":"Kaluve AM, Le JT, Graham BM. Female rodents are not more variable than male rodents: A meta-analysis of preclinical studies of fear and anxiety. Neurosci Biobehav Rev. 2022;143:104962.","journal-title":"Neurosci Biobehav Rev"},{"key":"810_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 2012;7:1009\u201314.","journal-title":"Nat Protoc"},{"key":"810_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/mol.119.118927","volume":"97","author":"MC Michel","year":"2020","unstructured":"Michel MC, Murphy TJ, Motulsky HJ. New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology. Mol Pharmacol. 2020;97:49\u201360.","journal-title":"Mol Pharmacol"},{"key":"810_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","volume":"21","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 1995;21:66\u201372.","journal-title":"Psychopharmacology"},{"key":"810_CR38","first-page":"111","volume":"4","author":"F Ferrari","year":"2011","unstructured":"Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S, et al. Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res. 2011;4:111\u201325.","journal-title":"J Pain Res"},{"key":"810_CR39","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/bph.14161","volume":"175","author":"JN Siemian","year":"2018","unstructured":"Siemian JN, Wang K, Zhang Y, Li JX. Mechanisms of Imidazoline I2 receptor agonist-induced antinociception in rats: involvement of monoaminergic neurotransmission. Br J Pharmacol. 2018;175:1519\u201334.","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00810-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:13:09Z","timestamp":1768342389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00810-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00810-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}